DOES ESTROGEN REPLACEMENT THERAPY PREDISPOSE TO THROMBOSIS?
- 11 January 1985
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 64 (S130) , 71-74
- https://doi.org/10.3109/00016348509157151
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinaseScandinavian Journal of Clinical and Laboratory Investigation, 1982
- ANTITHROMBIN III AND ORAL CONTRACEPTION WITH PROGESTAGEN-ONLY PREPARATIONThe Lancet, 1979
- SUBCUTANEOUS HEPARIN FOR THROMBOSIS IN PREGNANT WOMEN WITH HEREDITARY ANTITHROMBIN DEFICIENCYThe Lancet, 1979
- Antithrombin III deficiency, hypertriglyceridaemia, and venous thromboses.BMJ, 1978
- Familial Antithrombin III Deficiency as Pathogenesis of Deep Venous ThrombosisActa Medica Scandinavica, 1978
- Hereditary antithrombin iii deficiency and thromboembolic diseaseAmerican Journal of Hematology, 1976
- 17‐β‐OESTRADIOL AND THE FIBRINOLYTIC ACTIVITY OF VEIN WALLSBJOG: An International Journal of Obstetrics and Gynaecology, 1974
- Thrombosis and Oral Contraceptives: Possible PredispositionBMJ, 1973
- Low Fibrinolytic Activity of Veins During Treatment with Ethinylo EstradiolPublished by Wiley ,1971
- EFFECT OF COMBINED ŒSTROGEN-PROGESTOGEN ORAL CONTRACEPTIVES, ŒSTROGEN, AND PROGESTOGEN ON ANTIPLASMIN AND ANTITHROMBIN ACTIVITYThe Lancet, 1970